content_image/69803.jpg
## CORPORATE HEADQUARTERS 

Allergan, Inc. 2525 Dupont Drive P.O. Box 19534 Irvine, CA 92623-9534 (714) 246-4500 E-mail: corpinfo@allergan.com Internet: www.allergan.com 

## TRANSFER AGENT, REGISTRAR AND DIVIDEND DISBURSING AGENT, DUPLICATE MAILINGS 

EquiServe Trust Company, N.A. P.O. Box 43069 Providence, RI 02940-3069 (800) 446-2617 Hearing Impaired # TDD: (800) 952-9245 Internet: www.equiserve.com 

## ANNUAL MEETING OF STOCKHOLDERS 

The Annual Meeting of Stockholders of Allergan, Inc. will be held at The Irvine Marriott Hotel, 18000 Von Karman Avenue, Irvine, CA 92612, on April 28, 2004, at 10:00 a.m. 

## MARKET PRICES OF COMMON STOCK AND DIVIDENDS 

The following table shows the quarterly price range of the common stock and the cash dividends declared per share during the period listed. 

<img src='content_image/69803.jpg'>

Allergan common stock is listed on the New York Stock Exchange and is traded under the symbol “AGN.” In newspapers, stock information is frequently listed as “Alergn.” 

The approximate number of stockholders of record was 6,700 as of January 30, 2004. 

On June 29, 2002, Allergan distributed to its stockholders, in the form of a stock dividend, one share of its then wholly owned subsidiary, Advanced Medical Optics, Inc., for every 4.5 shares of common stock held on June 14, 2002. The 2002 stock prices presented above are restated stock prices and reflect the distribution of Allergan’s ownership in Advanced Medical Optics to its stockholders. (1) 

## FORM 10-K 

A copy of Allergan, Inc.’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission, is available through our Web site at www.allergan.com or without charge by contacting: 

## INVESTOR RELATIONS 

James M. Hindman Allergan, Inc. P.O. Box 19534 Irvine, CA 92623-9534 Phone: (714) 246-4636 Fax: (714) 246-4800 E-mail: corpinfo@allergan.com 

## DIVIDEND REINVESTMENT AND STOCK PURCHASE PLAN 

The plan allows Allergan stockholders to reinvest their dividends or invest cash in Allergan stock without brokerage commissions or service charges. If you are interested in joining the plan or would like more information, you may request a prospectus from: 

EquiServe Trust Company, N.A. Dividend Reinvestment Plan/Allergan, Inc. P.O. Box 43081 Providence, RI 02940-3081 

## TRADEMARKS 

Except as set forth below, all product names appearing in capital letters are trademarks or service marks that are owned by, licensed to, or promoted by Allergan, Inc., its subsidiaries or affiliates. The following Allergan trademarks appear in this report: ALOCRIL, ALPHAGAN, ALPHAGAN P, AVAGE, AZELEX, BOTOX, BOTOX Cosmetic, CELLUVISC, CELLUFRESH, COMBIGAN, ELESTAT, EXOCIN, FLUOROPLEX, LACRI-LUBE, LERIN, LIQUIFILM, LUMIGAN, MD FORTE, OCUFLOX, OFLOX, POSURDEX, PURITE, REFRESH, REFRESH CONTACTS, REFRESH ENDURA, REFRESH LIQUIGEL, REFRESH PLUS, REFRESH PM, REFRESH TEARS, RELESTAT, RELIEF, RESTASIS, TAZORAC, VISTABEL, ZORAC and ZYMAR. 

ACULAR and ACULAR LS are registered trademarks of Roche Palo Alto LLC. 

FINACEA is a registered trademark of Schering AG. 

Panzem is a registered trademark of EntreMed, Inc. 

Renova is a registered trademark of Johnson & Johnson. 

Allergan, for the year ending December 31, 2003, continued its proud tradition of placement in the top quartile for Environmental Health and Safety Performance within its Pharmaceutical Company peer group. More information on its 2003 performance worldwide can be found by accessing the corporate information section at www.allergan.com and pulling down the About Allergan section and clicking on the EH&S section. 

Market share numbers included in this Annual Report represent data from January 2003 to September 2003 unless otherwise noted. 

